Seth Klarman's Baupost Takes Profit On Stake In Elan Corp

HFA Padded
HFA Staff
Published on
Updated on

As Elan Corporation, plc (NYSE:ELN) and private investment firm Royalty Pharma were sparring over who got to buy Elan, Seth Klarman’s Baupost Group decided to take some profits on its investment in the biotechnology company. According to regulatory filings made with the Irish authority, Baupost has slashed its stake in Elan Corporation, plc (NYSE:ELN) from 9.1 million shares to 7.1 million shares. The ownership only represents a 1.39 percent position in Elan Corporation, plc (NYSE:ELN) and the regulatory filing was enforced because Elan is currently a takeover target. Seth Klarman and Elan Klarman bought a stake in Elan Corporation, plc (NYSE:ELN), a neuroscience…

This content is exclusively for paying members of Hedge Fund Alpha

Log In

Insider Strategies and Letters to Shareholders from the Top Hedge Funds and Maximize Your Portfolio Growth with Hedge Fund Alpha

Don’t have an account?

Subscribe now and get 7 days free!

HFA Padded

The post above is drafted by the collaboration of the Hedge Fund Alpha Team.